RKDA - Arcadia Biosciences GAAP EPS of -$0.42 misses by $0.12 revenue of $2.17M misses by $1.16M March, 30 2022 04:27 PM Arcadia Biosciences Inc. Arcadia Biosciences press release (NASDAQ:RKDA): Q4 GAAP EPS of -$0.42 misses by $0.12. Revenue of $2.17M (-69.6% Y/Y) misses by $1.16M. Shares -21.69%. For further details see: Arcadia Biosciences GAAP EPS of -$0.42 misses by $0.12, revenue of $2.17M misses by $1.16M